FDA Inspection 985195 — Southern Illinois Healthcare

Southern Illinois Healthcare — FEI 1470247

The FDA completed an inspection of Southern Illinois Healthcare on September 12, 2016 in Herrin, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 12, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Herrin, IL (United States)